cis-1,3,4,6,7,11b-Hexahydro-2-methyl-7-phenyl-2H-pyrazino[2,1-a] isoquinoline: a new atypical antidepressant.
Molecular modelling studies suggested the synthesis of cis-1,3,4,6,7, 11b-hexahydro-2-methyl-7-phenyl-2H-pyrazino[2,1-a]isoquinoline (7a) as a rigid analogue of the atypical antidepressant mianserin. Acylation of 2,2-diphenylethylamine with chloroacetyl chloride gives the chloroacetamide (2). Cyclization of 2 with P2O5 in xylene provides 1-(chloromethyl)-3,4-dihydro-4-phenylisoquinoline (3). Amination of 3, followed by reduction, gives the isomeric (aminomethyl)tetrahydroisoquinolines (4a and 5). Treatment of 4a with diethyl oxalate, followed by reduction of the diamide with borane, provides 7a. A variety of N-substituted, aromatic substituted, and optically resolved derivatives were prepared and evaluated for anticholinergic, antihistaminic, and antidepressant activity. In particular, the target cis isomer 7a as predicted from the modelling studies appears to possess excellent atypical antidepressant activity. This activity resides in the (+)-S,S optical isomer 10, which has the same absolute configuration as (+)-mianserin.
D000818:Animals; D000928:Antidepressive Agents / Q000138:chemical synthesis*; D001921:Brain / Q000378:metabolism; D004285:Dogs; D007099:Imipramine / Q000494:pharmacology; D007546:Isoquinolines / Q000138:chemical synthesis* / Q000494:pharmacology; D008803:Mianserin / Q000031:analogs & derivatives / Q000494:pharmacology; D008958:Models, Molecular; D011738:Pyrilamine / Q000378:metabolism; D011813:Quinuclidinyl Benzilate / Q000378:metabolism; D051381:Rats; D011950:Receptors, Cholinergic / Q000378:metabolism; D011968:Receptors, Histamine / Q000378:metabolism
D000928:Antidepressive Agents; D007546:Isoquinolines; D011950:Receptors, Cholinergic; D011968:Receptors, Histamine; D008803:Mianserin; D011813:Quinuclidinyl Benzilate; C042341:1,3,4,6,7,11b-hexahydro-2-methyl-7-phenyl-2H-pyrazino(2,1-a)isoquinoline; D011738:Pyrilamine; D007099:Imipramine